ATC Group: J01MA02 Ciprofloxacin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01MA02 in the ATC hierarchy

Level	Code	Title
`1`	J	Antiinfectives for systemic use
`2`	J01	Antibacterials for systemic use
`3`	J01M	Quinolone antibacterials
`4`	J01MA	Fluoroquinolones
`5`	J01MA02	Ciprofloxacin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	1 g
PAREN	Parenteral	0.5 g

Active ingredients in J01MA02

Active Ingredient
Ciprofloxacin
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.

Related product monographs

Document	Type	Information Source
CIPLOX Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)
CIPRO Film-coated tablet / Oral suspension kit	MPI, US: SPL/PLR	FDA, National Drug Code (US)
Ciproxin Tablets 250mg	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
MEDOCIPRIN Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
PROFLOXIN Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)
VIPROLOX Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)